AR086573A2 - Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica

Info

Publication number
AR086573A2
AR086573A2 ARP120101864A ARP120101864A AR086573A2 AR 086573 A2 AR086573 A2 AR 086573A2 AR P120101864 A ARP120101864 A AR P120101864A AR P120101864 A ARP120101864 A AR P120101864A AR 086573 A2 AR086573 A2 AR 086573A2
Authority
AR
Argentina
Prior art keywords
octeno
azabiciclo
piridin
octano
therapeutics
Prior art date
Application number
ARP120101864A
Other languages
English (en)
Inventor
Frederic Galli
Odile Leclerc
Alistair Lochead
Alain Nedelec
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR086573A2 publication Critical patent/AR086573A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto que se selecciona entre los siguientes compuestos: bromohidrato de 5-(2-fenilpiridin-5-il)-1-azabiciclo[3.2.1]oct-3-eno (2:1); bromohidrato de 5-(2-fenilpiridin-5-il)-1-azabiciclo[3.2.1]octano (2:1); bromohidrato de 5-(2-fenilpiridin-5-il)-1-azabiciclo[3.2.1]oct-2-eno (2:1).
ARP120101864A 2002-01-07 2012-05-28 Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica AR086573A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR086573A2 true AR086573A2 (es) 2014-01-08

Family

ID=8871176

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP030100009A AR038098A1 (es) 2002-01-07 2003-01-03 Derivados de 5-(piridin-3-il)-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica
ARP120101864A AR086573A2 (es) 2002-01-07 2012-05-28 Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP030100009A AR038098A1 (es) 2002-01-07 2003-01-03 Derivados de 5-(piridin-3-il)-1- azabiciclo [3.2.1] octano, su preparacion y su aplicacion en terapeutica

Country Status (36)

Country Link
US (2) US7223750B2 (es)
EP (1) EP1465893B1 (es)
JP (1) JP4402957B2 (es)
KR (1) KR100977332B1 (es)
CN (2) CN1911928A (es)
AR (2) AR038098A1 (es)
AT (1) ATE355290T1 (es)
AU (1) AU2003216777B2 (es)
BR (1) BR0306707A (es)
CA (1) CA2471628C (es)
CO (1) CO5590914A2 (es)
CY (1) CY1106580T1 (es)
DE (1) DE60312123T2 (es)
DK (1) DK1465893T3 (es)
EA (1) EA007793B1 (es)
EC (1) ECSP045176A (es)
ES (1) ES2281631T3 (es)
FR (1) FR2834511B1 (es)
HK (1) HK1066547A1 (es)
HR (1) HRP20040617B1 (es)
IL (2) IL162524A0 (es)
IS (1) IS2470B (es)
MA (1) MA27165A1 (es)
ME (2) ME00213B (es)
MX (1) MXPA04006630A (es)
NO (1) NO329309B1 (es)
NZ (1) NZ533793A (es)
PL (1) PL216665B1 (es)
PT (1) PT1465893E (es)
RS (1) RS50921B (es)
SI (1) SI1465893T1 (es)
TN (1) TNSN04120A1 (es)
TW (1) TWI336703B (es)
UA (1) UA77229C2 (es)
WO (1) WO2003057697A1 (es)
ZA (1) ZA200405002B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) * 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101928505B1 (ko) 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) * 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
JP7065180B2 (ja) 2017-11-03 2022-05-11 アルコン インク. 眼疾患を治療するためのアザビシクロ及びジアゼピン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
WO1995003306A1 (en) 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
EA200400770A1 (ru) 2004-12-30
CN1276921C (zh) 2006-09-27
PL216665B1 (pl) 2014-04-30
AU2003216777B2 (en) 2008-10-02
ECSP045176A (es) 2004-08-27
PL370065A1 (en) 2005-05-16
KR20040077705A (ko) 2004-09-06
RS59904A (en) 2006-10-27
ME00213B (me) 2011-02-10
TW200305413A (en) 2003-11-01
FR2834511B1 (fr) 2004-02-13
CN1911928A (zh) 2007-02-14
CA2471628C (en) 2011-03-22
US20050020568A1 (en) 2005-01-27
IS2470B (is) 2008-12-15
CA2471628A1 (en) 2003-07-17
JP4402957B2 (ja) 2010-01-20
PT1465893E (pt) 2007-05-31
BR0306707A (pt) 2005-02-09
FR2834511A1 (fr) 2003-07-11
CO5590914A2 (es) 2005-12-30
KR100977332B1 (ko) 2010-08-20
HK1066547A1 (en) 2005-03-24
TNSN04120A1 (fr) 2006-06-01
HRP20040617A2 (en) 2004-10-31
ES2281631T3 (es) 2007-10-01
JP2005514422A (ja) 2005-05-19
US20070185137A1 (en) 2007-08-09
CY1106580T1 (el) 2012-01-25
NZ533793A (en) 2007-01-26
TWI336703B (en) 2011-02-01
MEP24408A (en) 2010-10-10
ZA200405002B (en) 2006-05-31
NO329309B1 (no) 2010-09-27
MXPA04006630A (es) 2004-11-10
NO20042846L (no) 2004-09-21
DE60312123T2 (de) 2007-09-13
SI1465893T1 (sl) 2007-08-31
IS7322A (is) 2004-06-16
DK1465893T3 (da) 2007-06-04
AU2003216777A1 (en) 2003-07-24
RS50921B (sr) 2010-08-31
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
HRP20040617B1 (hr) 2012-10-31
MA27165A1 (fr) 2005-01-03
AR038098A1 (es) 2004-12-29
UA77229C2 (uk) 2006-11-15
IL162524A (en) 2010-05-17
US7585974B2 (en) 2009-09-08
US7223750B2 (en) 2007-05-29
DE60312123D1 (de) 2007-04-12
IL162524A0 (en) 2005-11-20
ATE355290T1 (de) 2006-03-15
EP1465893B1 (fr) 2007-02-28
EP1465893A1 (fr) 2004-10-13
WO2003057697A1 (fr) 2003-07-17

Similar Documents

Publication Publication Date Title
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
EA200500017A1 (ru) Новые соединения
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
AU2002246728A1 (en) Carboline derivatives
WO2004087053A3 (en) Dipeptidyl peptidase inhibitors
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
NO20055565D0 (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
AR025739A1 (es) Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
AU2003228770A1 (en) Substituted pyrazolopyrimidines
UY28897A1 (es) Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb
MXPA02011370A (es) Iminoazinas substituidas.
AU2002249890A1 (en) Carboline derivatives
YU39803A (sh) Jedinjenja piperazinilpirazina kao agonisti ili antagonisti serotonin 5ht-2-receptora
AU2001266575A1 (en) Chemical compounds
MXPA05011212A (es) Derivados de indeno como agentes farmaceuticos.
RS50229B (sr) Analozi vitamina d3
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
CO4940435A1 (es) Sal de hemisulfato del (1s,4r)-cis-4-[2-amino-6- (ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol o un solvato del mismo
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
DE60008400D1 (de) Triazolopyrimidinderivate

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee